News

MGD011 is a humanized CD19 x CD3 bispecific DART protein being developed to treat B-cell hematological malignancies. As part of the deal, MacroGenics will secure a $50m upfront

The company said that ENV515 is a fully biodegradable particle replication in non-wetting templates (PRINT) particle formulation of a prostaglandin analog, travoprost, with the potential for sustained intraocular

Fomepizole , an alcohol dehydrogenase inhibitor , is marketed and distributed by Paladin Labs Inc. ( "Paladin" ) in Canada and is the standard treatment for ethylene glycol

CRN, the leading trade association for the dietary supplement and functional food industry, developed these guidelines in response to recommendations from authoritative medical organizations, including the American Academy

Novel approaches to understanding the complex failures of the blood-brain-barrier that result in neurodegeneration are welcome. Innovation should lead to the cure therapies that do not exist today,

Together with the National Institute of Allergy and Infectious Diseases (NIAID), WCCT-Global is currently conducting influenza infection studies in healthy volunteers and is the first CRO to conduct

The patent is expected to expire no earlier than its twenty-year term in 2032. RayVa is the proprietary name for Apricus’ product candidate for the treatment of Raynaud’s

The approval has already been given in the 28 EU member states and in the US, based on study data showing that Velphoro can control hyperphosphatemia with fewer

The risk of dementia is said to be high when the so-called anticholinergic drugs are taken in high doses over several years. Anticholinergics are a class of drug